Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
BlackRock has unveiled an unprecedented $400 billion private markets fundraising target through 2030, signaling the world's largest asset manager's strategic pivot toward alternative investments....
Forward Air Corporation (NASDAQ:FWRD) has become the focal point of intense private equity interest as Blackstone, Apollo Global Management, Platinum Equity, and Clearlake Capital engage in...
Spanish banking group Banco Sabadell has initiated a strategic pivot by exploring the sale of its UK subsidiary TSB Bank, marking a critical juncture in its decade-long British expansion. This move...
Mitsubishi Corporation stands poised to make its largest-ever acquisition with a potential $8 billion purchase of Aethon Energy Management's U.S. shale gas assets, according to multiple sources...
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17,...
The acquisition of CW Advisors by Osaic represents a pivotal moment in the ongoing consolidation of the registered investment advisor (RIA) sector, combining Audax Private Equity’s operational...
Charlotte-based Bojangles has engaged investment bankers to explore a potential sale that could value the fried chicken chain at $1.5 billion – nearly triple its 2019 acquisition price – as...
The Pennsylvania House of Representatives has passed landmark legislation (House Bill 1460) imposing unprecedented oversight on private-equity healthcare transactions, marking a watershed moment in...
In a landmark consolidation of Germany's biotechnology sector, BioNTech SE (NASDAQ: BNTX) has announced its acquisition of CureVac NV (NASDAQ: CVAC) through an all-stock transaction valued at $1.25...
The accelerating separation of US and Chinese tech ecosystems reached a pivotal moment this week as Fidelity-backed Eight Roads Ventures announced plans to divest its entire portfolio of 40 Chinese...
